Zosano Pharma
(OTC) ZSAN
Zosano Pharma Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$659.00K
Net Income (TTM)
$55.32M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ZSAN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Zosano Pharma
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
40
CEO
Steven Lo
Website
www.zosanopharma.comHeadquarters
Fremont, CA 94555, US
ZSAN Financials
Key Financial Metrics (TTM)
Gross Margin
-1%
Operating Margin
-38%
Net Income Margin
-38%
Return on Equity
-75%
Return on Capital
-80%
Return on Assets
-62%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$11.00K
Operating Income
$29.74M
EBITDA
$27.98M
Operating Cash Flow
$27.59M
Capital Expenditure
$5.42M
Free Cash Flow
$33.01M
Cash & ST Invst.
$11.04M
Total Debt
$9.48M
Zosano Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$132.00K
-48.8%
Gross Profit
$46.00K
-52.1%
Gross Margin
34.85%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
40
N/A
Net Income
$33.48M
-311.2%
EBITDA
$33.09M
-334.8%
Quarterly Fundamentals
Net Cash
$7.49M
-34.3%
Accounts Receivable
$107.00K
-56.0%
Inventory
$0.00
N/A
Long Term Debt
$2.66M
-66.4%
Short Term Debt
$3.38M
-55.2%
Return on Assets
-62.23%
N/A
Return on Invested Capital
-79.81%
N/A
Free Cash Flow
$8.61M
+19.5%
Operating Cash Flow
$8.54M
-14.5%